These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37802080)

  • 1. Claudio Castanos-leader in cystic fibrosis care in Argentina.
    Kirby T
    Lancet Respir Med; 2023 Oct; 11(10):871. PubMed ID: 37802080
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of three novel mutations in the cystic fibrosis transmembrane conductance regulator gene in Argentinian CF patients.
    Bienvenu T; Chertkoff L; Beldjord C; Segal E; Carniglia L; Barreiro C; Kaplan JC
    Hum Mutat; 1996; 7(4):376-7. PubMed ID: 8723695
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel, mechanism-based therapies for cystic fibrosis.
    Rubenstein RC
    Curr Opin Pediatr; 2005 Jun; 17(3):385-92. PubMed ID: 15891431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Fetal Cystic Fibrosis With Cystic Fibrosis Transmembrane Conductance Regulator Modulation Therapy.
    Blumenfeld YJ; Hintz SR; Aziz N; Barth RA; Spano JM; El-Sayed YY; Milla C
    Ann Intern Med; 2023 Jul; 176(7):1015-1016. PubMed ID: 37307583
    [No Abstract]   [Full Text] [Related]  

  • 5. Cystic fibrosis: frequency of delta f508 and g542x mutations in Cordoba, Argentina.
    Saleh MC; Botelli A; Melano de Botelli M; Rezzonico CA; Argaraña CE
    Medicina (B Aires); 1996; 56(1):14-6. PubMed ID: 8734924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Perry LA; Penny-Dimri JC; Aslam AA; Lee TW; Southern KW
    Paediatr Respir Rev; 2017 Mar; 22():47-49. PubMed ID: 27964951
    [No Abstract]   [Full Text] [Related]  

  • 7. Current progress in cystic fibrosis: is this a disease elusive to therapy?
    Brown C
    Pulm Pharmacol Ther; 2008 Aug; 21(4):585-7. PubMed ID: 18313958
    [No Abstract]   [Full Text] [Related]  

  • 8. Making precision medicine personal for cystic fibrosis.
    Manfredi C; Tindall JM; Hong JS; Sorscher EJ
    Science; 2019 Jul; 365(6450):220-221. PubMed ID: 31320522
    [No Abstract]   [Full Text] [Related]  

  • 9. [Protein repair therapy in cystic fibrosis].
    Clément A; Tamalet A; Fauroux B; Epaud R
    Rev Prat; 2003 Jan; 53(2):163-6. PubMed ID: 12664848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New therapies in cystic fibrosis.
    Ratjen F; Grasemann H
    Curr Pharm Des; 2012; 18(5):614-27. PubMed ID: 22229570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalised medicine for cystic fibrosis: treating the basic defect.
    Elborn JS
    Eur Respir Rev; 2013 Mar; 22(127):3-5. PubMed ID: 23457158
    [No Abstract]   [Full Text] [Related]  

  • 12. How do cystic fibrosis transmembrane conductance regulator mutations produce lung disease?
    Pilewski JM; Frizzell RA
    Curr Opin Pulm Med; 1995 Nov; 1(6):435-43. PubMed ID: 9363079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bespoke Babies: Genome Editing in Cystic Fibrosis Embryos.
    Brothers KB; Devereaux M; Sade RM
    Ann Thorac Surg; 2019 Oct; 108(4):995-999. PubMed ID: 31152729
    [No Abstract]   [Full Text] [Related]  

  • 14. New approaches to cystic fibrosis.
    Moss RB
    Hosp Pract (1995); 2001 Jan; 36(1):25-7, 31-2, 35-7. PubMed ID: 11197941
    [No Abstract]   [Full Text] [Related]  

  • 15. Population screening of F508del (DeltaF508), the most frequent mutation in the CFTR gene associated with cystic fibrosis in Argentina.
    Roqué M; Godoy CP; Castellanos M; Pusiol E; Mayorga LS
    Hum Mutat; 2001 Aug; 18(2):167. PubMed ID: 11462248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic fibrosis.
    Welsh MJ; Smith AE
    Sci Am; 1995 Dec; 273(6):52-9. PubMed ID: 8525348
    [No Abstract]   [Full Text] [Related]  

  • 17. Innovations in the treatment of cystic fibrosis: outriders for the treatment of diseases with other genetic defects?
    Schubert-Zsilavecz M; Merk D
    Future Med Chem; 2011 Dec; 3(16):1969-70. PubMed ID: 22098344
    [No Abstract]   [Full Text] [Related]  

  • 18. [Challenges of personalized medicine for cystic fibrosis].
    Corvol H; Taytard J; Tabary O; Le Rouzic P; Guillot L; Clement A
    Arch Pediatr; 2015 Jul; 22(7):778-86. PubMed ID: 26021452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial overview: Respiratory: Transformational therapies for cystic fibrosis.
    Sheppard DN; Bear CE; de Jonge HR
    Curr Opin Pharmacol; 2017 Jun; 34():viii-xi. PubMed ID: 29221574
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial: Emerging Molecular Targets for the Treatment of Cystic Fibrosis.
    Yang Z; Sun F; Li C
    Curr Drug Targets; 2015; 16(9):922. PubMed ID: 26323277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.